Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma (Q33428348)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

Donatella Marino

object named as

D Marino

15

0 references

object named as

C Belli

10

0 references

author name string

S Cereda

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

M Milella

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

S Cordio

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

F Leone

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

G Aprile

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

A Galiano

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

S Mosconi

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

E Vasile

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

D Santini

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

A Auriemma

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

A Novarino

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

V Vaccaro

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

C Martines

14

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

S E Lutrino

16

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

V Palazzo

17

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

B Reinach

18

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

L Aldrighetti

19

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

M Reni

20

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

10 December 2015

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

77

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

109-114

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2919-0

21 January 2018

Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2919-0

21 January 2018

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2919-0

21 January 2018

Biliary tract carcinomas: from chemotherapy to targeted therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2919-0

21 January 2018

Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2919-0

21 January 2018

Phase II trial of mitomycin C (MMC) in advanced gallbladder and biliary tree carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group Study

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2919-0

21 January 2018

Mitomycin C: a review

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2919-0

21 January 2018

Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2919-0

21 January 2018

The role of capecitabine in the management of tumors of the digestive system

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2919-0

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2919-0

21 January 2018

A pilot study to investigate the role of thymidylate synthase as a marker of prognosis for neoadjuvant chemotherapy in gastric and gastro-oesophageal junction adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2919-0

21 January 2018

Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: the association with treatment efficacy of pemetrexed.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2919-0

21 January 2018

Second-line therapy in advanced biliary tract cancer: what should be the standard?

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2919-0

21 January 2018

Imatinib mesylate for palliative second-line treatment of advanced biliary tract cancer: a bicentric phase II study

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2919-0

21 January 2018

Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy: a phase II ITMO study

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2919-0

21 January 2018

Second-line chemotherapy in advanced biliary cancer: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2919-0

21 January 2018

Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2919-0

21 January 2018

Prognostic and predictive value of thymidine phosphorylase activity in early-stage breast cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2919-0

21 January 2018

Thymidylate synthase protein expression in colorectal cancer metastases predicts for clinical outcome to leucovorin-modulated bolus or infusional 5-fluorouracil but not methotrexate-modulated bolus 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2919-0

21 January 2018

Reproducible immunohistochemical criteria based on multiple raters' judgments for expression of thymidine phosphorylase in breast cancer tissue

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2919-0

21 January 2018

Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2919-0

21 January 2018

Thymidylate synthase and thymidine phosphorylase as predictive markers of capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2919-0

21 January 2018

Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2919-0

21 January 2018

Identifiers

10.1007/S00280-015-2919-0

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33428348&oldid=2195352878"